Release Date: 30/07/14 10:00 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 1.2MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%